Special Issue "Emerging Marine Toxins"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2014)
Prof. Dr. Vítor Vasconcelos
1. CIIMAR – Interdisciplinary Centre of Marine and Environmental Research, Matosinhos, Portugal 2. Department of Biology, Faculty of Sciences, Porto University, Porto 4069-007, Portugal
Website | E-Mail
Phone: +351 223401814
Fax: +351 223380609
Interests: blue-biotechnology; emerging marine toxins; bioassay-guided approach; cyanobacteria bioactive compounds
Marine toxins produced by dinoflagellates and diatoms, including domoic acid, ocadaic acid, and the saxitoxins group, are monitored regularly in most countries. This action decreases the risk of human intoxication and is fundamental for the trading of shellfish outside the borders of producing countries. Recently, emerging toxins, such as tetrodotoxins, ciguatoxins, palytoxins and analogues, cyclic imines, and others, which mostly occur in tropical regions, are being reported from more temperate waters. This shift in occurrences may reflect more intense biological invasions, better analytical techniques or more attention being given (to these toxins) by researchers. Nevertheless, these emerging toxins have been poisoning humans (especially in the North Atlantic and Mediterranean regions). It is therefore essential that more precise and accurate analytical techniques are developed, so that the actual situation is clearly assessed. A clearer understanding is crucial for addressing our need for new guidelines regarding how to manage some of these toxins.
This special issue will cover all emerging toxins that may be a threat to human and environmental health, and which are not yet covered by legislation.
Prof. Dr. Vítor Vasconcelos
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- emerging marine toxins
- cyclic imines
- analytical methods
- risk assessment
- environmental and human health
- biological invasions
- global changes